TSX | NYSE: ACB
Appoints Carey
Squires as Executive Vice President, Corporate Development
& Strategy
EDMONTON, April 4, 2019
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora")
(NYSE: ACB) (TSX: ACB) today announced that the Company has
appointed Carey Squires as its
Executive Vice President of Corporate Development and Strategy. In
this newly created role, reporting to the Executive Chairman, Mr.
Squires in collaboration with senior executives across the company
will focus on global growth and partnership strategies and investor
development.
Mr. Squires comes to Aurora with global investment banking
experience, having most recently served as Managing Director and
Co-Head of Equity-Linked Capital Markets for BMO Capital Markets.
In this role, he successfully led the financing for a number of
issuers, including Aurora's recent convertible notes offering. Mr.
Squires received a B.Sc from the University of
British Columbia as well as an MBA from the Rotman School of
Management at the University of
Toronto.
"With deep experience in the U.S. and Canadian capital markets,
Carey has been a trusted advisor to Aurora on a variety of growth
initiatives, including our recently successful capital raise," said
Michael Singer, Executive Chairman
of Aurora. "In this new position, Carey will be a core member of
Aurora's senior management team, executing on the development of
key strategic initiatives, including partnerships and M&A
opportunities. We look forward to working closely with Carey to
leverage his extensive knowledge in the execution of our investor
development, international growth and partnership strategies,
sourcing potential accretive opportunities in the global cannabis
industry and negotiating favourable business transactions."
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 500,000 kg per
annum and sales and operations in 24 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high quality product at low cost. Intended to be replicable and
scalable globally, our production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and low per gram production costs. Each of
Aurora's facilities is built to meet EU GMP standards, and its
first production facility, the recently acquired MedReleaf Markham
facility, and its wholly owned European medical cannabis
distributor Aurora Deutschland have achieved this level of
certification.
In addition to the Company's rapid organic growth and strong
execution on strategic M&A, which to date includes 15 wholly
owned subsidiary companies – MedReleaf, CanvasRX, Peloton
Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator,
BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics,
Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela,
and ICC Labs – Aurora is distinguished by its reputation as a
partner and employer of choice in the global cannabis sector,
having invested in and established strategic partnerships with a
range of leading innovators, including: Radient Technologies Inc.
(TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group
Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom
Holdings Inc. (CSE: CHOO), Capcium Inc. (private), Evio Beauty
Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC:
CTTH), Alcanna Inc. (TSX: CLIQ) and High Tide Inc. (CSE:HITI).
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and are a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com
Neither the TSX, NYSE nor their Regulation Services Provider
(as that term is defined in the policies of the TSX and NYSE)
accepts responsibility for the adequacy or accuracy of this
release.
Terry Booth, CEO
Aurora Cannabis Inc.
Forward-Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"), including, but not
limited to, statements with respect to the performance of the
Company. Forward-looking statements are frequently characterized by
words such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These statements are
only predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-expands-management-team-to-support-strategic-initiatives-300824452.html
SOURCE Aurora Cannabis Inc.